Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Bristol-Myers Squibb Co (BMY)

3K + Investors. Track Smart Money conviction in BMY. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +108
Streak
2Q ▲
Buyers last Q
56%

Smart Money Signals — BMY

Based on 2530 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added BMY than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
2,530 hedge funds hold BMY right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +4% more funds vs a year ago

fund count last 6Q
+97 new funds entered over the past year (+4% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 56% buying

1361 buying1077 selling
Last quarter: 1,361 funds bought or added vs 1,077 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-80 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 167 → 170 → 374 → 294. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

72% of holders stayed for 2+ years

■ 72% conviction (2yr+) ■ 14% medium ■ 14% new
1,821 out of 2,530 hedge funds have held BMY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

224 → 167 → 170 → 374 → 294 new funds/Q
New funds entering each quarter: 167 → 170 → 374 → 294. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 75% veterans vs 16% newcomers

■ 75% veterans ■ 9% 1-2yr ■ 16% new
Entry-cohort mix of 2,614 holders: 1,954 (75%) are 2+ year veterans, 239 entered 1–2 years ago, and 421 (16%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 49% AUM from top-100 funds

49% from top-100 AUM funds
67 of 2511 holders are among the 100 largest funds by AUM, controlling 49% of total institutional value in BMY. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.5
out of 10
Low Exit Risk
Exit risk score 3.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — BMY

In 2026 Q1, 1361 hedge funds were net buyers of BMY (294 opened a new position, 1067 added to an existing one), while 1077 reduced or exited (891 trimmed, 186 sold completely) — a 56% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 49% of total institutional value in BMY is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +108 funds (more new holders than closures). Total institutional holders: 2530.

Hedge Fund Ownership: BMY

How many hedge funds hold BMY — quarterly history vs. share price
Quarterly hedge fund ownership of BMY vs. share price

Market Analysis: BMY

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: BMY

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Bristol-Myers Squibb Co (BMY) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much BMY has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
BMY
-5.8%
XLV
+4.9%

BMY outperformed XLV by -10.7% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
BMY
+0.2%
XLV
+6.0%

Since the filing became public, BMY outperformed XLV by -5.8% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

115 top-rated funds 20 high-conviction
Consensus
9.0
/ 10
breadth
×
Elite
4.7
/ 10
conviction
Hedge Fund Positioning: BMY
3K + Investors

Track Smart Money conviction in BMY. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 2505 2422 3.43%
13F Shares 1.56B 1.68B -7.16%
Total Value $89.65B $89.74B -0.1%
New Positions 288 374 -86
Increased Positions 1035 857 +178
Closed Positions 205 186 +19
Reduced Positions 860 943 -83
Total Calls 54 41 31.71%
Total Puts 49 45 8.89%
PUT/CALL Ratio 0.91 1.1 Neutral

Statistics: BMY

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

3K + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BMY. Verified SEC 13F-HR filings.

QUARTER:
Top 25 BMY holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Chiron Capital Management, LLC 11.89% 191,288 $11.6M
2 Sector Gamma As 11.86% 827,901 $50.2M
3 Birchview Capital, LP 10.57% 306,268 $18.6M
4 Independent Franchise Partners LLP 9.03% 21,275,474 $1.29B
5 Catalio Capital Management, LP 5.33% 420,727 $25.5M
6 Nepsis Inc. 5.33% 262,182 $15.9M
7 Colrain Capital LLC 4.75% 202,445 $12.3M
8 Sofinnova Investments, Inc. 4.58% 1,988,721 $120.6M
9 Humankind Investments LLC 3.46% 100,000 $6.1M
10 Pzena Investment Management LLC 3.37% 17,095,731 $1.04B
11 FourWorld Capital Management LLC 3.09% 100,000 $6.1M
12 Abacus FCF Advisors LLC 3.06% 224,000 $13.6M
13 Leibman Financial Services, Inc. 2.98% 66,907 $4.1M
14 Miramar Capital, LLC 2.90% 214,738 $13.0M
15 Round Hill Asset Management 2.88% 72,431 $4.4M
16 Lombard Odier Asset Management (USA) Corp 2.85% 450,000 $27.3M
17 Bourne Lent Asset Management Inc 2.85% 127,816 $7.8M
18 Catherine Avery Investment Management LLC 2.85% 104,863 $6.4M
19 Quantessence Capital LLC 2.69% 9,119 $553K
20 Cambiar Investors LLC 2.65% 944,246 $57.3M
21 Keystone Financial Planning, Inc. 2.58% 159,523 $9.7M
22 Sippican Capital Advisors 2.52% 60,689 $3.7M
23 Stance Capital LLC 2.48% 84,197 $5.1M
24 Ikarian Capital, LLC 2.46% 500,000 $30.3M
25 Integras Partners LLC 2.33% 58,584 $3.6M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Bristol-Myers Squibb Co (BMY)

What does the Smart Money Trend signal show for BMY?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added BMY than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for BMY?

Slight buying edge — 56% buying: Last quarter: 1,361 funds bought or added vs 1,077 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for BMY holders?

Elite ownership — 49% AUM from top-100 funds: 67 of 2511 holders are among the 100 largest funds by AUM, controlling 49% of total institutional value in BMY. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held BMY?

72% of holders stayed for 2+ years: 1,821 out of 2,530 hedge funds have held BMY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Bristol-Myers Squibb Co (BMY) following the 2026 Q1 hedge fund 13F filings?

As of today, BMY has moved +0.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -5.8%. Since the quarter end (March 31, 2026), BMY has gained -5.8% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →